Shuai Shi

Title: Innovations by Inventor Shuai Shi

Introduction

Shuai Shi is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative formulations for treating various disorders. With a total of 3 patents to his name, his work is recognized for its potential impact on medical treatments.

Latest Patents

Shuai Shi's latest patents include formulations of anti-LAG3 antibodies and co-formulations of anti-LAG3 antibodies and anti-PD-1 antibodies. These inventions provide formulations that are crucial for treating various disorders. Another significant patent involves a pharmaceutical formulation comprising incretin-insulin conjugates. This disclosure relates to stable aqueous pharmaceutical formulations that contain a therapeutically effective amount of an incretin-insulin conjugate. The formulations are designed to be stable and provide a protracted pharmacodynamics profile, which includes L-arginine HCl and phenol (or m-cresol) as stabilizing agents. This invention also outlines a method for treating patients with metabolic diseases by administering effective amounts of the described formulations.

Career Highlights

Shuai Shi is currently associated with Merck Sharp & Dohme Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to developing effective treatments that can improve patient outcomes.

Collaborations

Shuai Shi has collaborated with notable colleagues such as Valentyn Antochshuk and Ramesh Kashi, contributing to a dynamic research environment that fosters innovation.

Conclusion

In summary, Shuai Shi is a distinguished inventor whose work in pharmaceutical formulations has the potential to transform treatment methodologies. His contributions are vital to advancing medical science and improving patient care.